FeesSafety
Pluang+

Franklin Templeton boosts tokenized sgBENJI shares on XRP Ledger to $200M, expanding institutional crypto use.

Protocol Fundamentals
24 Oct 2026
Coingape
View Source
Bullish
Franklin Templeton boosts tokenized sgBENJI shares on XRP Ledger to $200M, expanding institutional crypto use.

Franklin Templeton increased its tokenized sgBENJI shares on the XRP Ledger by about $150 million, nearly quadrupling its holdings to nearly 193 million shares valued around $200 million. This move highlights growing institutional adoption of tokenized real-world assets on blockchain, supported by multi-signature wallets for regulatory compliance. Franklin's position now ranks second among tokenized asset issuers on XRPL, behind Ripple's RLUSD. The expansion follows partnerships enabling fund token trading and collateral use, signaling deeper integration of traditional finance with blockchain technology.

Franklin Templeton's addition of $150 million in sgBENJI shares on the XRP Ledger provides context for market activity. For readers following cryptocurrency trends, here is Pluang's market snapshot as of Oct 24, 2026 13:31 WIB: out of 50 major cryptocurrencies, 6 rose and 43 fell. Notable moves include SAND at Rp915 with a 7.43% decline and a 60% sell order activity, ONE at Rp25 with a 97% buy order activity, and ATOM at Rp30,176 with a 6.08% drop.

More News

AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker has introduced a comprehensive Business Class Flight Routes Guide to help travelers from the US explore premium flight options to 15 major international destinations across Asia, Europe, Africa, and Australia. The guide covers airlines, ...

Others
Neutral
1 hour ago
Darolutamide with ADT and radiation cuts metastasis or death risk by 58% in high-risk prostate cancer patients.

Darolutamide with ADT and radiation cuts metastasis or death risk by 58% in high-risk prostate cancer patients.

Interim results from the Phase 3 DASL-HiCaP trial show that adding darolutamide to standard androgen deprivation therapy (ADT) and radiation therapy reduces the risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence...

Company Fundamentals
Bullish
3 hours ago
Anthropic's revenue jumps to $16.3B in H1 2026, up from $1.1B last year

Anthropic's revenue jumps to $16.3B in H1 2026, up from $1.1B last year

Anthropic reported a massive increase in revenue, reaching $16.3 billion in the first half of 2026 compared to just $1.1 billion in the same period last year. This surge highlights rapid growth and strong demand for its products or services. The dram...

Market News
Bullish
4 hours ago
NEAR Protocol leads crypto losses with an 8.93% drop amid broader market declines

NEAR Protocol leads crypto losses with an 8.93% drop amid broader market declines

NEAR Protocol (NEAR) experienced the largest 24-hour decline among major cryptocurrencies, falling 8.93% to $4.47. Other notable drops included Bitcoin down 1.28% to $80,495, Ether down 1.38% to $2,360.57, and XRP down 3.45% to $1.28. These declines ...

Market News
Bearish
4 hours ago
XRP's 2017-18 rally gains estimated between 62,000% and 119,000%, varying by measurement methods.

XRP's 2017-18 rally gains estimated between 62,000% and 119,000%, varying by measurement methods.

Estimates of XRP's price rally during 2017-18 vary widely, from about 62,000% to 119,000%, depending on different starting prices and measurement periods. Vandell Aljarrah of Black Swan Capitalist highlighted a 630-fold rise when XRP moved above a tr...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App